GFM
ALT icon

GF Fund Management’s Altimmune ALT Stock Holding History

GF Fund Management’s Portfolio ALT Stock Details ALT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$7.18K Buy
2,331
+282
+14% +$1.2K ﹤0.01% 585
2025
Q4 		$7.4K Buy
2,049
+150
+8% +$654 ﹤0.01% 603
2025
Q3 		$7.16K Buy
1,899
+78
+4% +$301 ﹤0.01% 581
2025
Q2 		$7.05K Hold
1,821
– – ﹤0.01% 602
2025
Q1 		$9.11K Buy
1,821
+328
+22% +$2.08K ﹤0.01% 577
2024
Q4 		$10.8K Buy
+1,493
New +$11.4K ﹤0.01% 531

Other funds holding ALT

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return

GF Fund Management's ALT Position: Q1 2026 in Review

GF Fund Management increased its Altimmune (ALT) stake by 14% in Q1 2026, buying an estimated $1.2K and bringing the position to 2,331 shares worth $7.18K. The position accounts for ﹤0.01% of the portfolio, ranked #585.

GF Fund Management first reported a position in ALT in Q4 2024 and has held it in 6 quarters since. The position peaked at $10.8K in Q4 2024. 173 funds tracked by Wall St. Rank hold ALT as of Q1 2026.

  • GF Fund Management held 2,331 shares of Altimmune worth $7.18K as of Q1 2026.
  • GF Fund Management bought 282 Altimmune shares in Q1 2026, an estimated $1.2K.
  • Altimmune made up ﹤0.01% of GF Fund Management's portfolio in Q1 2026, its #585 holding.
  • GF Fund Management first reported a position in Altimmune in Q4 2024 and has held it in 6 quarters since.
  • GF Fund Management's Altimmune position peaked at $10.8K in Q4 2024.
  • 173 funds tracked by Wall St. Rank held Altimmune as of Q1 2026.

Based on GF Fund Management's 13F filing for Q1 2026, filed 15 Apr 2026.